+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Insomnia Drugs Market by Drug Class (Antihistamines, Benzodiazepines, Melatonin Receptor Agonists), Formulation (Capsules, Injectables, Oral Suspensions), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Insomnia Drugs Market by Drug Class (Antihistamines, Benzodiazepines, Melatonin Receptor Agonists), Formulation (Capsules, Injectables, Oral Suspensions), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Insomnia Drugs Market by Drug Class (Antihistamines, Benzodiazepines, Melatonin Receptor Agonists), Formulation (Capsules, Injectables, Oral Suspensions), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889526
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Insomnia Drugs Market is evolving rapidly, with shifting therapeutic preferences, innovations in digital health, and changing regulatory demands all impacting how treatment is developed, prescribed, and delivered. Senior decision-makers need clear, actionable insight to navigate this dynamic environment and optimize strategies for sustainable growth and resilience.

Market Snapshot: Insomnia Drugs Market Size and Outlook

The Insomnia Drugs Market grew from USD 3.07 billion in 2024 to USD 3.25 billion in 2025. It is expected to continue growing at a CAGR of 5.77%, reaching USD 4.30 billion by 2030. Demand is driven by evolving patient expectations, advances in neurobiology, and expanding digital integration, which are encouraging pharmaceutical companies to diversify portfolios and adopt new approaches.

Scope & Segmentation

This report delivers a detailed analysis of the insomnia drug market, focusing on current trends, product segmentation, and regional developments. The report covers a range of therapies, formulations, distribution models, and user settings critical to understanding the landscape.

  • Drug Classes: Antihistamines, Benzodiazepines, Melatonin Receptor Agonists, Non-Benzodiazepines (including Eszopiclone, Zaleplon, Zolpidem), Orexin Receptor Antagonists (Daridorexant, Lemborexant, Suvorexant).
  • Formulations: Capsules, Tablets, Sublingual Tablets, Oral Suspensions, Injectables.
  • Administration Routes: Oral, Intravenous, Sublingual, Transdermal.
  • Distribution Channels: Drug Stores, Retail Pharmacies (Chain, Independent, Supermarket), Hospital Pharmacies (Private, Public), Online Pharmacies (General B2C Platforms, Manufacturer Direct Sites, Telepharmacy Services).
  • End Users: Hospitals (Private, Public), Ambulatory Care Centers, Home Care, Clinics.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and more).
  • Companies Profiled: Sanofi S.A., Sunovion Pharmaceuticals Inc., Merck & Co., Inc., Eisai Co., Ltd., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Avadel Pharmaceuticals plc, Idorsia Ltd., Viatris Inc.

Key Takeaways for Senior Decision-Makers

  • Therapeutic diversification is intensifying as non-benzodiazepine hypnotics and orexin receptor antagonists reshape prescribing habits, providing more flexible and targeted intervention options for clinicians and patients.
  • Emerging digital health integration, including telepharmacy services and wearable sleep trackers, is enhancing real-time patient monitoring and facilitating robust post-market surveillance, driving the adoption of data-driven treatment models.
  • Formulation innovation enables tailored delivery modes—including sublingual, injectable, and transdermal options—to better serve both chronic and acute cases, catering to diverse patient profiles across multiple care settings.
  • Regulatory complexity is increasing, with authorities demanding comprehensive cognitive assessments and longer follow-up periods, requiring pharmaceutical companies to invest in more rigorous clinical trial designs and post-marketing surveillance mechanisms.
  • Collaborative partnerships between pharmaceutical and digital health firms are becoming pivotal, as integration of technology platforms supports patient engagement, adherence, and the generation of valuable real-world evidence.
  • Global and regional players are leveraging acquisition, partnership, and real-world data strategies to bolster competitiveness and optimize product portfolios to meet evolving stakeholder needs.

Tariff Impact: Navigating US Supply Chain & Compliance Shifts

U.S. tariff measures introduced in 2025 on imported active pharmaceutical ingredients have raised costs for manufacturers and forced a reassessment of procurement and sourcing strategies. Companies are evaluating domestic partnerships, vertical integration, and supply chain diversification to stabilize costs, while new customs and documentation requirements have increased the need for robust trade compliance systems. Successful supply resilience depends on proactive adaptation to these policy shifts.

Methodology & Data Sources

This report is built on primary interviews with clinicians, supply chain executives, and regulatory experts, backed by panels to validate findings. Secondary research included regulatory filings, peer-reviewed publications, and company disclosures, with advanced analytics applied to map trends and performance metrics. Expert validation workshops ensured accuracy and relevance for strategic decisions.

Why This Report Matters

  • Offers actionable insights to guide portfolio diversification, digital health integration, and strategic partnerships in a fast-evolving insomnia drugs market.
  • Clarifies key regulatory and supply chain challenges, enabling risk mitigation and policy adaptation for efficient market access.
  • Provides thorough coverage of segments, regional trends, and the competitive landscape to inform investment decisions and stakeholder engagement.

Conclusion

The insomnia drugs market is marked by growing performance complexity, digital and scientific innovation, and emerging compliance challenges. Companies equipped with informed strategies for product, distribution, and organizational agility are better positioned for continued growth and resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid growth of orexin receptor antagonists supported by emerging real-world safety and efficacy evidence
5.2. Integration of digital therapeutics and cognitive behavioral therapy modules with insomnia drugs for personalized treatment pathways
5.3. Impact of COVID-19-induced sleep disturbances on prescription patterns and long-term demand for insomnia medications
5.4. Regulatory scrutiny and post-marketing surveillance intensification for Z-drugs amid dependency and cognitive risk concerns
5.5. Surging interest in melatonin receptor agonists for expanding off-label use in pediatric and geriatric insomnia management strategies
5.6. Development and clinical trial advancements of non-sedative anxiolytic compounds targeting insomnia with comorbid depression
5.7. Emergence of wearable sleep monitoring devices and AI-driven analytics guiding real-time dose adjustment of insomnia drugs
5.8. Market entry of novel dual orexin receptor antagonists driving competitive formulary placement and pricing pressures
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Insomnia Drugs Market, by Drug Class
8.1. Introduction
8.2. Antihistamines
8.3. Benzodiazepines
8.4. Melatonin Receptor Agonists
8.5. Non-Benzodiazepines
8.5.1. Eszopiclone
8.5.2. Zaleplon
8.5.3. Zolpidem
8.6. Orexin Receptor Antagonists
8.6.1. Daridorexant
8.6.2. Lemborexant
8.6.3. Suvorexant
9. Insomnia Drugs Market, by Formulation
9.1. Introduction
9.2. Capsules
9.3. Injectables
9.4. Oral Suspensions
9.5. Sublingual Tablets
9.6. Tablets
10. Insomnia Drugs Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
10.4. Sublingual
10.5. Transdermal
11. Insomnia Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Drug Stores
11.3. Hospital Pharmacies
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Online Pharmacies
11.4.1. General B2C Platforms
11.4.2. Manufacturer Direct Sites
11.4.3. Telepharmacy Services
11.5. Retail Pharmacies
11.5.1. Chain Pharmacies
11.5.2. Independent Pharmacies
11.5.3. Supermarket Pharmacies
12. Insomnia Drugs Market, by End User
12.1. Introduction
12.2. Ambulatory Care Centers
12.3. Clinics
12.4. Home Care
12.5. Hospitals
12.5.1. Private Hospitals
12.5.2. Public Hospitals
13. Americas Insomnia Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Insomnia Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Insomnia Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Sanofi S.A.
16.3.2. Sunovion Pharmaceuticals Inc.
16.3.3. Merck & Co., Inc.
16.3.4. Eisai Co., Ltd.
16.3.5. Takeda Pharmaceutical Company Limited
16.3.6. Johnson & Johnson
16.3.7. Teva Pharmaceutical Industries Ltd.
16.3.8. Avadel Pharmaceuticals plc
16.3.9. Idorsia Ltd.
16.3.10. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INSOMNIA DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INSOMNIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. INSOMNIA DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. INSOMNIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. INSOMNIA DRUGS MARKET: RESEARCHAI
FIGURE 26. INSOMNIA DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. INSOMNIA DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. INSOMNIA DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INSOMNIA DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INSOMNIA DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INSOMNIA DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MELATONIN RECEPTOR AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MELATONIN RECEPTOR AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ESZOPICLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ESZOPICLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZALEPLON, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZALEPLON, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZOLPIDEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZOLPIDEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DARIDOREXANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DARIDOREXANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY LEMBOREXANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY LEMBOREXANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUVOREXANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUVOREXANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY GENERAL B2C PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY GENERAL B2C PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT SITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT SITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TELEPHARMACY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TELEPHARMACY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUPERMARKET PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUPERMARKET PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 155. CANADA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 156. CANADA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 157. CANADA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 158. CANADA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 159. CANADA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 160. CANADA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 161. CANADA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 162. CANADA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 163. CANADA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. CANADA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. CANADA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 168. CANADA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 169. CANADA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 170. CANADA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 171. CANADA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 172. CANADA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 173. CANADA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. CANADA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. CANADA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 176. CANADA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 180. MEXICO INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 181. MEXICO INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. MEXICO INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. MEXICO INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. MEXICO INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. MEXICO INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 190. MEXICO INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 191. MEXICO INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 192. MEXICO INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 193. MEXICO INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 194. MEXICO INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 195. MEXICO INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. MEXICO INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. MEXICO INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 289. GERMANY INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 290. GERMANY INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 291. GERMANY INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 292. GERMANY INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 293. GERMANY INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 294. GERMANY INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 295. GERMANY INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 296. GERMANY INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 297. GERMANY INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 298. GERMANY INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 299. GERMANY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. GERMANY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. GERMANY INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 302. GERMANY INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 303. GERMANY INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 304. GERMANY INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 305. GERMANY INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 306. GERMANY INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 307. GERMANY INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. GERMANY INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. GERMANY INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 310. GERMANY INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 311. FRANCE INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 312. FRANCE INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 313. FRANCE INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 314. FRANCE INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 315. FRANCE INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 316. FRANCE INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 317. FRANCE INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 318. FRANCE INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 319. FRANCE INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. FRANCE INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. FRANCE INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. FRANCE INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. FRANCE INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 324. FRANCE INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 325. FRANCE INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 326. FRANCE INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 327. FRANCE INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 328. FRANCE INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 329. FRANCE INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. FRANCE INSOMNIA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. FRANCE INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 332. FRANCE INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 333. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 334. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 335. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2024 (USD MILLION)
TABLE 336. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Insomnia Drugs market report include:
  • Sanofi S.A.
  • Sunovion Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Eisai Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Avadel Pharmaceuticals plc
  • Idorsia Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.3 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Insomnia Pharmacological Treatment Market by Drug Class (Benzodiazepines, Melatonin Receptor Agonists, Non Benzodiazepine Hypnotics), Dosage Form (Capsules, Oral Suspension, Tablets), Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Insomnia Pharmacological Treatment Market by Drug Class (Benzodiazepines, Melatonin Receptor Agonists, Non Benzodiazepine Hypnotics), Dosage Form (Capsules, Oral Suspension, Tablets), Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Insomnia Therapeutics Market Size, Share & Trends Analysis Report by Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), Sales Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Insomnia Therapeutics Market Size, Share & Trends Analysis Report by Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), Sales Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Insomnia Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Insomnia Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 92 Pages
  • Global
From
Insomnia Therapeutics Market 2025-2029 - Product Image

Insomnia Therapeutics Market 2025-2029

  • Report
  • 205 Pages
  • Global
From
Insomnia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Insomnia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Market

The Insomnia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Insomnia drugs are used to treat difficulty sleeping, and can be divided into two categories: sedative-hypnotics and non-sedative hypnotics. Sedative-hypnotics are drugs that act on the central nervous system to induce sleep, while non-sedative hypnotics are drugs that act on the brain to improve sleep quality without causing sedation. Commonly prescribed insomnia drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists. Some companies in the Insomnia Drug market include Sanofi, Pfizer, Merck, GlaxoSmithKline, and Takeda. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.